Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 08/05/2024 at 16:18, 1 year 7 months ago

Jaguar Health Issues Shareholder Letter: Company to Explore Approval Pathway for Crofelemer in Breast and Lung Cancer Based on Phase 3 Results - Investor Webcast August 13th Will Review Q2 Earnings and Further Review OnTarget Trial’s Clinically Meaningf
Jaguar Health, Inc. issued a letter to shareholders regarding the upcoming webcast to review second-quarter earnings and clinical data from the recent phase 3 OnTarget trial of crofelemer for breast and lung cancer patients

Crofelemer Webcast Jaguar Health Breast Cancer Lung Cancer
BRIEF

published on 08/02/2024 at 16:05, 1 year 7 months ago

Elaine Elisabetsky, PhD, to Discuss Plant-Based Schizophrenia Treatments

Jaguar Health Magdalena Biosciences Schizophrenia Plant-based Medicine Ethnopharmacology
BRIEF

published on 08/02/2024 at 16:05, 1 year 7 months ago

Elaine Elisabetsky, PhD, discutera des traitements contre la schizophrénie à base de plantes

Magdalena Biosciences Schizophrénie Santé Jaguar Médecine À Base De Plantes Ethnopharmacologie
PRESS RELEASE

published on 08/02/2024 at 16:00, 1 year 7 months ago

Elaine Elisabetsky, PhD, Member of Jaguar Health's Mental Health Entheogen Therapeutics Initiative, to Speak August 2nd About Plant-Based Medicines Used to Manage Schizophrenia at the University of Illinois Chicago College of Pharmacy
Dr. Elisabetsky conducts research on plant-based medicines for mental health conditions. Jaguar out-licenses botanical drug for schizophrenia treatment to Magdalena Biosciences

Jaguar Health Magdalena Biosciences Schizophrenia Dr. Elisabetsky Plant-based Medicines
BRIEF

published on 06/26/2024 at 14:35, 1 year 8 months ago

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement

Crofelemer Jaguar Health Nasdaq Compliance OnTarget Trial Cancer Supportive Care
BRIEF

published on 06/26/2024 at 14:35, 1 year 8 months ago

Jaguar Health retrouve sa conformité avec l'exigence de prix acheteur du Nasdaq

Crofelemer Santé Jaguar Conformité Au Nasdaq Essai OnTarget Soins De Soutien Contre Le Cancer
PRESS RELEASE

published on 06/26/2024 at 14:30, 1 year 8 months ago

Jaguar Health Regains Compliance with Nasdaq's Bid Price Requirement
JAGX's securities remain listed and traded on Nasdaq as Jaguar announces regaining compliance with Nasdaq's bid price requirement. Updates on cancer supportive care drug crofelemer OnTarget trial results expected by July 23, 2024

Crofelemer Nasdaq Jaguar Health OnTarget Trial JAGX
BRIEF

published on 06/21/2024 at 22:20, 1 year 9 months ago

Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders

Crofelemer Podcast Jaguar Health OnTarget Trial World Rainforest Day
BRIEF

published on 06/21/2024 at 22:20, 1 year 9 months ago

Jaguar Health annonce l’approbation de toutes les propositions lors de l’assemblée annuelle des actionnaires de juin 2024

Crofelemer Podcast Santé Jaguar Essai OnTarget Journée Mondiale De La Forêt Tropicale
PRESS RELEASE

published on 06/21/2024 at 22:15, 1 year 9 months ago

Jaguar Health Reports Approval of All Proposals at June 2024 Annual Meeting of Stockholders
Jaguar Health, Inc. to report pivotal phase 3 OnTarget trial results for cancer supportive care drug crofelemer by July 23, 2024. Investor webcast and podcast interview updates included

Crofelemer Investor Webcast Jaguar Health OnTarget Trial Cancer Supportive Care

Published on 03/25/2026 at 19:15, 1 hour 45 minutes ago

Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/25/2026 at 13:30, 7 hours 30 minutes ago

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada
Published on 03/25/2026 at 13:30, 7 hours 30 minutes ago

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification
Published on 03/25/2026 at 13:30, 7 hours 30 minutes ago

Strategic Metals Closes Project Sale
Published on 03/25/2026 at 13:25, 7 hours 35 minutes ago

Predictiv AI Expands Active Deployment of CloudRep.ai Across Healthcare, Retail, Real Estate, Travel and Global Markets

View all ACCESSWIRE

Published on 03/25/2026 at 20:00, 1 hour ago

Piramal Pharma Solutions Commemorates 20th Anniversary at Morpeth Facility with Procurement of Korsch X3 Tablet Press
Published on 03/25/2026 at 19:41, 1 hour 19 minutes ago

EQS-Adhoc: STRATEC POSTS IMPAIRMENTS, REPORTS PRELIMINARY RESULTS FOR 2025, AND OFFERS GUIDANCE FOR 2026
Published on 03/25/2026 at 19:30, 1 hour 30 minutes ago

AIXTRON to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 19:26, 1 hour 33 minutes ago

EQS-Adhoc: AIXTRON SE to expand global footprint with new plant in Malaysia
Published on 03/25/2026 at 18:40, 2 hours 20 minutes ago

TULKUBASH AND KYZYLTASH MINING ASSETS: DECLARATION FROM A GROUP OF INVESTORS

View all EQS

Published on 03/25/2026 at 18:53, 2 hours 6 minutes ago

CIS - Transfert Contrat de Liquidité Portzamparc - 25.03.2026
Published on 03/25/2026 at 18:53, 2 hours 7 minutes ago

LNA SANTE : 2025 Annual Results
Published on 03/25/2026 at 18:31, 2 hours 29 minutes ago

Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 18:31, 2 hours 29 minutes ago

Performance soutenue des Investissements et déploiement actif de la stratégie
Published on 03/25/2026 at 18:06, 2 hours 53 minutes ago

LNA SANTE : Résultats Annuels 2025

View all LES ECHOS COMFI WIRE

News